[1] Kawasaki Y.Mechanism of onset and exacerbation of chronic glomerulonephritis and its treatment[J].Pediatrics International, 2015, 53(6): 795-806. [2] Svetyy LI, Lopukhova VA, Tarasenko IV.Evaluation of pharmacotherapy with perindopril, losartan potassium, and their combination in elderly patients with chronic heart failure[J].Advances in Gerontology, 2016, 6(1): 67-69. [3] 中华中医药学会肾病分会.慢性肾小球肾炎的诊断、辨证分型及疗效评定(试行方案)[J].上海中医药杂志,2006,40(6):8-9. [4] 郑筱萸.中药新药临床研究指导原则(试行)[M].北京:中国医药科技出版社,2002,3(2):247-248. [5] Kamyshova ES, Shvetsov MY, Kutyrina IM, et al.Clinical value of TNF, IL-6, and IL-10 gene polymorphic markers in chronic glomerulonephritis[J]. Ter Arkh, 2016, 88(6): 45-50. [6] 齐振强,李伟.李伟教授运用补肾化瘀清泄法治疗慢性肾脏病经验[J].中国中西医结合肾病杂志,2017,18(12):1038-1040. [7] 徐达,吴颢昕.从气阴两虚论治慢性肾炎蛋白尿[J].中国中医基础医学杂志,2017,23(5),714-716. [8] 刘西强,何峰,孙飞虎,等.国医大师朱良春安全应用虫类药之经验[J]. 广州中医药大学学报,2015,32(4):759-761. [9] 崔明明,马晓燕.马晓燕教授治疗慢性肾小球肾炎蛋白尿经验[J]. 云南中医中药杂志,2019,40(3):1-2. [10] 李淑芳. 中药黄芪药理作用研究进展[J].湖北中医杂志,2013,35(6):73-75. [11] 王振华,张倩,刘建平,等.依折麦布对冠心病患者血脂代谢及颈动脉斑的影响[J].第三军医大学学报,2016,38(21):2345-2348. [12] Yuhong Z, Ran P, Wang Z, et al.Zhibitai and low-dose atorvastatin reduce blood lipids and inflammation in patients with coronary artery[J]. Medicine(Baltimore), 2017, 96(7): e6104. |